LEXARIA BIOSCIENCE CORP. Payments to Acquire Oil and Gas Property
LEXARIA BIOSCIENCE CORP. (LEXX) reported Payments to Acquire Oil and Gas Property of $0 for the 6-month period ending 2015-02-28, per its 10-Q filed 2015-04-14.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireOilAndGasProperty · last filed 2015-04-14
- LEXARIA BIOSCIENCE CORP. payments to acquire oil and gas property for the quarter ending 2014-11-30 was $0.00, a 100.00% decline year-over-year.
- LEXARIA BIOSCIENCE CORP. payments to acquire oil and gas property for the quarter ending 2014-07-31 was $2.00, a 98.00% decline year-over-year.
- LEXARIA BIOSCIENCE CORP. payments to acquire oil and gas property for the quarter ending 2014-04-30 was $31.42K, a 15.77% increase year-over-year.
- LEXARIA BIOSCIENCE CORP. payments to acquire oil and gas property for the quarter ending 2014-01-31 was $25.00K, a 32.69% decline year-over-year.
- LEXARIA BIOSCIENCE CORP. payments to acquire oil and gas property for fiscal 2013 was $91.61K, a 66.58% decline from fiscal 2012.
- LEXARIA BIOSCIENCE CORP. payments to acquire oil and gas property for fiscal 2012 was $274.13K, a 72.66% decline from fiscal 2011.
- LEXARIA BIOSCIENCE CORP. payments to acquire oil and gas property for fiscal 2011 was $1.00M, a 251.50% increase from fiscal 2010.
- LEXARIA BIOSCIENCE CORP. payments to acquire oil and gas property for fiscal 2010 was $285.24K.
| Period end | Payments to Acquire Oil and Gas Property 3 month | Payments to Acquire Oil and Gas Property 6 month | Payments to Acquire Oil and Gas Property 9 month | Payments to Acquire Oil and Gas Property 10 month | Payments to Acquire Oil and Gas Property 12 month | Payments to Acquire Oil and Gas Property 12 month as first filed |
|---|---|---|---|---|---|---|
| 2015-02-28 | $0.00 10-Q · filed 2015-04-14 | |||||
| 2014-11-30 | $0.00 10-Q · filed 2015-01-14 | |||||
| 2014-08-31 | $68.62K 10-KT · filed 2014-12-09 | |||||
| 2014-07-31 | $2.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-14 | $31.42K derived: sum of 2 quarters · filed 2014-11-14 | $56.42K 10-Q · filed 2014-11-14 | |||
| 2014-04-30 | $31.42K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-06-12 | $56.42K 10-Q · filed 2014-06-12 | ||||
| 2014-02-28 | -$67.53K 10-Q · filed 2015-04-14 | |||||
| 2014-01-31 | $25.00K 10-Q · filed 2014-03-12 | |||||
| 2013-11-30 | $64.38K 10-Q · filed 2015-01-14 | |||||
| 2013-10-31 | $27.23K derived: 10-KT 12 month − 10-Q 9 month · filed 2014-12-09 | $27.33K derived: sum of 2 quarters · filed 2014-12-09 | $54.47K derived: sum of 3 quarters · filed 2014-12-09 | $91.61K 10-KT · filed 2014-12-09 | ||
| 2013-08-31 | $64.38K 10-KT · filed 2014-12-09 | |||||
| 2013-07-31 | $100.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-14 | $27.24K derived: sum of 2 quarters · filed 2014-11-14 | $64.38K 10-Q · filed 2014-11-14 | $91.42K derived: sum of 4 quarters · filed 2014-11-14 | ||
| 2013-04-30 | $27.14K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-06-12 | $64.28K 10-Q · filed 2014-06-12 | $91.32K derived: sum of 3 quarters · filed 2014-06-12 | $293.21K derived: sum of 4 quarters · filed 2014-06-12 | ||
| 2013-01-31 | $37.14K 10-Q · filed 2014-03-12 | $64.18K derived: sum of 2 quarters · filed 2014-03-12 | $266.07K derived: sum of 3 quarters · filed 2014-03-12 | $266.07K derived: sum of 4 quarters · filed 2014-03-12 | ||
| 2012-10-31 | $27.04K derived: 10-K 12 month − 10-Q 9 month · filed 2014-01-24 | $228.93K derived: sum of 2 quarters · filed 2014-01-24 | $228.93K derived: sum of 3 quarters · filed 2014-01-24 | $274.13K 10-K · filed 2014-01-24 | ||
| 2012-07-31 | $201.89K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-09-10 | $201.89K derived: sum of 2 quarters · filed 2013-09-10 | $247.09K 10-Q · filed 2013-09-10 | $968.56K derived: sum of 4 quarters · filed 2013-09-10 | ||
| 2012-04-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2013-06-12 | $45.20K 10-Q · filed 2013-06-12 | $766.67K derived: sum of 3 quarters · filed 2013-06-12 | $766.67K derived: sum of 4 quarters · filed 2013-06-12 | ||
| 2012-01-31 | $45.20K 10-Q · filed 2013-03-13 | $766.67K derived: sum of 2 quarters · filed 2013-03-13 | $766.67K derived: sum of 3 quarters · filed 2013-03-13 | $805.96K derived: sum of 4 quarters · filed 2013-03-13 | ||
| 2011-10-31 | $721.47K derived: 10-K 12 month − 10-Q 9 month · filed 2013-01-29 | $721.47K derived: sum of 2 quarters · filed 2013-01-29 | $760.75K derived: sum of 3 quarters · filed 2013-01-29 | $1.00M 10-K · filed 2013-01-29 | $697.69K 10-K · filed 2012-01-30 | |
| 2011-07-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2012-09-12 | $39.29K derived: sum of 2 quarters · filed 2012-09-12 | $281.16K 10-Q · filed 2012-09-12 | $566.41K derived: sum of 4 quarters · filed 2012-09-12 | ||
| 2011-04-30 | $39.29K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-06-07 | $281.16K 10-Q · filed 2012-06-07 | $566.41K derived: sum of 3 quarters · filed 2012-06-07 | |||
| 2011-01-31 | $241.88K 10-Q · filed 2012-03-13 | $527.12K derived: sum of 2 quarters · filed 2012-03-13 | ||||
| 2010-10-31 | $285.24K derived: 10-K 12 month − 10-Q 9 month · filed 2012-01-30 | $285.24K 10-K · filed 2012-01-30 | ||||
| 2010-07-31 | $0.00 10-Q · filed 2011-09-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Telomir Pharmaceuticals, Inc. (TELO) | United States | $0.084B | |
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B | |
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B | ||
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |